Zilascorb

Drug Profile

Zilascorb

Alternative Names: P 1015; Zoxxoz

Latest Information Update: 15 Dec 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pronova Biocare
  • Class Antineoplastics
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Colorectal cancer; Malignant melanoma; Ovarian cancer; Pancreatic cancer

Most Recent Events

  • 15 Dec 1998 A clinical study has been added to the therapeutic trials and adverse events sections
  • 30 Apr 1996 Discontinued-II for Colorectal cancer in United Kingdom (Unknown route)
  • 30 Apr 1996 Discontinued-II for Malignant melanoma in Australia (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top